The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II efficacy trial of pazopanib in nonclear cell metastatic renal cell cancer (mRCC): PINCR.
 
Brian Addis Costello
Research Funding - GlaxoSmithKline/Novartis (Inst)
 
Thai Huu Ho
Consulting or Advisory Role - Cardinal Health; Exelixis; Ipsen; Pfizer; Roche/Genentech
Research Funding - Novartis
 
Gabriela Perez Burbano
No Relationships to Disclose
 
David W. Hillman
No Relationships to Disclose
 
Fernando Quevedo
No Relationships to Disclose
 
Henry C. Pitot
No Relationships to Disclose
 
Lance C. Pagliaro
Research Funding - Genentech/Roche; Pfizer
Travel, Accommodations, Expenses - Merck; Roche
 
Alan Haruo Bryce
Honoraria - Astellas Pharma
Travel, Accommodations, Expenses - Clovis Oncology
 
Winston Tan
Honoraria - Medscape
 
Richard Wayne Joseph
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Exelixis; Genoptix; Merck (Inst); Nektar; Novartis
Research Funding - Amgen (Inst); Bristol-Myers Squibb; Merck; Roche/Genentech (Inst); X4 Pharma (Inst)
 
Bradley C. Leibovich
No Relationships to Disclose
 
Erik P. Castle
No Relationships to Disclose
 
Roxana Stefania Dronca
Research Funding - Merck Sharp & Dohme (Inst)
Other Relationship - Elsevier
 
Manish Kohli
Travel, Accommodations, Expenses - Celgene